Published in Healthcare Finance, Tax and Law Weekly, June 14th, 2006
According to a study from Italy, "hTERT, the catalytic subunity of telomerase, a marker of cell immortalization, is upregulated in most tumors, including NSCLC. However, little is known about the role of assessing cell-free plasma circulating hTERT mRNA for tracing these tumors."
"We investigated by RT-polymerase chain reaction (PCR) and real-time quantitative PCR the prevalence and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly